Falk CS - Search Results

1

Harnessing innate and adaptive immunity for adoptive cell therapy of renal cell carcinoma.

Geiger C, Nössner E, Frankenberger B, Falk CS, Pohla H, Schendel DJ. Geiger C, et al. Among authors: falk cs. J Mol Med (Berl). 2009 Jun;87(6):595-612. doi: 10.1007/s00109-009-0455-2. Epub 2009 Mar 7. J Mol Med (Berl). 2009. PMID: 19271159 Review.

2

Expression of HLA-C molecules confers target cell resistance to some non-major histocompatibility complex-restricted T cells in a manner analogous to allospecific natural killer cells.

Falk CS, Steinle A, Schendel DJ. Falk CS, et al. J Exp Med. 1995 Oct 1;182(4):1005-18. doi: 10.1084/jem.182.4.1005. J Exp Med. 1995. PMID: 7561674 Free PMC article.

3

MHC class I allorecognition: the likes and dislikes of CTL and NK cells.

Reinhardt C, Falk C, Steinle A, Schendel DJ. Reinhardt C, et al. Behring Inst Mitt. 1994 Jul;(94):61-71. Behring Inst Mitt. 1994. PMID: 7998916 Review.

4

The HLA likes and dislikes of allospecific and non-MHC-restricted cytotoxic T lymphocytes.

Nössner E, Falk CS, Jantzer P, Reinhardt C, Steinle A, Schendel DJ. Nössner E, et al. Among authors: falk cs. Immunol Rev. 1996 Dec;154:105-35. doi: 10.1111/j.1600-065x.1996.tb00931.x. Immunol Rev. 1996. PMID: 9034865 Review. No abstract available.

5

HLA-C revisited. Ten years of change.

Falk CS, Schendel DJ. Falk CS, et al. Immunol Res. 1997;16(2):203-14. doi: 10.1007/BF02786363. Immunol Res. 1997. PMID: 9212365 Review.

6

Cellular and molecular analyses of major histocompatibility complex (MHC) restricted and non-MHC-restricted effector cells recognizing renal cell carcinomas: problems and perspectives for immunotherapy.

Schendel DJ, Oberneder R, Falk CS, Jantzer P, Kressenstein S, Maget B, Hofstetter A, Riethmüller G, Nössner E. Schendel DJ, et al. Among authors: falk cs. J Mol Med (Berl). 1997 Jun;75(6):400-13. doi: 10.1007/s001090050125. J Mol Med (Berl). 1997. PMID: 9231880 Review.

7

Gene transfer of human interferon gamma complementary DNA into a renal cell carcinoma line enhances MHC-restricted cytotoxic T lymphocyte recognition but suppresses non-MHC-restricted effector cell activity.

Schendel DJ, Falk CS, Nössner E, Maget B, Kressenstein S, Urlinger S, Tampé R, Gansbacher B. Schendel DJ, et al. Among authors: falk cs. Gene Ther. 2000 Jun;7(11):950-9. doi: 10.1038/sj.gt.3301187. Gene Ther. 2000. PMID: 10849555

8

Non-MHC-restricted CD4+ T lymphocytes are regulated by HLA-Cw7-mediated inhibition.

Falk CS, Nössner E, Frankenberger B, Schendel DJ. Falk CS, et al. Hum Immunol. 2000 Dec;61(12):1219-32. doi: 10.1016/s0198-8859(00)00218-4. Hum Immunol. 2000. PMID: 11163077

9

Calcium signaling through the beta 2-cytoplasmic domain of LFA-1 requires intracellular elements of the T cell receptor complex.

Sirim P, Zeitlmann L, Kellersch B, Falk CS, Schendel DJ, Kolanus W. Sirim P, et al. Among authors: falk cs. J Biol Chem. 2001 Nov 16;276(46):42945-56. doi: 10.1074/jbc.M103224200. Epub 2001 Sep 14. J Biol Chem. 2001. PMID: 11559699 Free article.

10

Retaliation against tumor cells showing aberrant HLA expression using lymphokine activated killer-derived T cells.

Falk CS, Noessner E, Weiss EH, Schendel DJ. Falk CS, et al. Cancer Res. 2002 Jan 15;62(2):480-7. Cancer Res. 2002. PMID: 11809699

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

244 results

Search Page